Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1491-6. doi: 10.1073/pnas.022630299. Epub 2002 Jan 15.

Abstract

T lymphocytes are defective in cystine uptake and thus require exogenous thiols for activation and function. Here we show that monocyte-derived human dendritic cells (DCs) release cysteine in the extracellular space. Cysteine generation is increased by lipopolysaccharide and tumor necrosis factor alpha, and by contact with T cells specifically recognizing soluble or alloantigens. These stimuli also induce thioredoxin (TRX) accumulation in DCs. However, only the contact with antigen-specific T cells triggers TRX secretion by the antigen-presenting cells. Fewer extracellular thiols are recovered after DC-T cell interactions when cystine uptake or TRX activity are inhibited. In addition, glutamate (Glu) and anti-TRX-inactivating antibodies inhibit antigen-dependent T lymphocyte proliferation. These findings indicate that, during antigen presentation, DCs uptake cystine and release cysteine and TRX, thus providing a reducing microenvironment that facilitates immune response.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigen-Presenting Cells / immunology*
  • CD40 Ligand / pharmacology
  • Cell Communication
  • Cell Separation / methods
  • Cells, Cultured
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Humans
  • Immunoglobulin G
  • Kinetics
  • L-Lactate Dehydrogenase / analysis
  • Lipopolysaccharides / pharmacology
  • Lymphocyte Activation*
  • Mice
  • Oxidation-Reduction
  • Sulfhydryl Compounds / metabolism
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Immunoglobulin G
  • Lipopolysaccharides
  • Sulfhydryl Compounds
  • Tumor Necrosis Factor-alpha
  • CD40 Ligand
  • L-Lactate Dehydrogenase